Scholars Central

EditorialPublished 2019

Transition of Intervention of Clinical Trials for Obesity

Authors: Sato H

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

ABSTRACTObjectives: Earlier studies have revealed thatmodification of lifestyle habits from the aspects ofnutrition and exercise is the most effective measure tocontrol metabolic syndrome, and this finding may bereflected in the number of registered clinical trials.This paper aims to test this assumption and conductexploratory analysis of the recent trends in clinicaltrials related to obesity.Design and methods: Of the clinical trial dataregistered with the International Clinical TrialRegistry Platform (ICTRP), we used 1,478 data sets ofobese patients for analysis (available as of August2016). This study is exploratory analysis, aiming totest some hypotheses and identify the overalltendency. The target hypotheses are as follows.Among clinical trials targeting obese patients, theamount of these intended to verify the effect oflifestyle modification has been increasing year byyear. Results: the share of clinical trials targetingobesity has been increasing year by year. We clearlyfound that the amount of clinical trials using lifestyleintervention has been increasing .In the study conducted by Knowler in 2002, theresearch team divided obese patients with BMI25 orhigher into three groups, i.e., those given a placebo,those treated with metformin, and those instructed tomodify their lifestyle, and observed their conditionsover four years. The research team found that thecumulative incidence of diabetes was statisticallysignificantly lower among the lifestyle modificationgroup than among the metformin group. Following anumber of similar study results, more importance hasbeen given to lifestyle modification than to treatmentwith mediation as a strategy to control obesity, ormetabolic syndrome. Leading the planet during thisarea, Japan introduced a system of specified medicalcheckups and specified medical guidance in 2008.Under this technique , people receiving medicalcheckups undergo measurement of their waistcircumference, BMI, then forth. The system isdesigned to thereby find people who are at risk oflifestylerelated diseases due to high blood sugar, highblood pressure, and lipid abnormality, from amongthose whose measurement results exceed the standardranges. These people are given health guidance toswitch their lifestyle habits. Other countries followedJapan, starting to implement government-led measures tomodify people’s lifestyle habits including diet andexercise. Backed up by a number of study results such asthose obtained by Sacks and Eyles , the first bill in theUnited States to levy tax on soda and other sugarsweetenedbeverages was passed by the council of theCity of Berkeley, California . A similar soda tax is alsoscheduled to be introduced in the City of Philadelphia .This trend has the potential of spreading across theUnited States.Thus, earlier studies have revealed that modificationof lifestyle habits from the aspects of nutrition andexercise is the most effective measure to controlmetabolic syndrome, and this finding may be reflected inthe number of registered clinical trials. Presumably,among clinical trials targeting obese patients, while theamount of trials using surgery and drugs has beenrelatively decreasing year by year, the amount of theseintended to verify the effect of lifestyle modification hasbeen relatively increasing year by year. This paper aimsto test this assumption and conduct exploratory analysisof the recent trends in clinical trials related to obesityIn the Advanced search of ICTRP [7], when inputtingthe disease name in the condition column, data of thecorresponding clinical trial is output. In this study, weentered “obesity” within the condition field of Advancedsearch and analyzed the info of all clinical trials output.Of the clinical trial data registered with the InternationalClinical Trial Registry Platform (ICTRP) [8], we used1,478 data sets of obese patients for analysis (all fromdatabase inception to August 19, 2016)In order to analyze these hypotheses, we extracteddata regarding Date Registration, Study Type, Gender,Minimum Age, Maximum Age, and Phase, from the1,478 data sets mentioned above. We also read dataregarding interventions one by one and classified thedata into five categories, i.e. Surgery, Device,Supplement, Lifestyle Habits, and Other. Anintervention that may fall within more than one category,such as modification of lifestyle habits after surgery, isclassified as “Surgery.” Other interventions that may fallwithin more than one category are classified into thecategory of more invasive intervention. “Device” coversa good range, including implantable devices,communication devices for remote medical aid , andeven video games. “Supplement” mainly includesvitamin tablets and plant extracts. As “Lifestyle Habits,” we selected nutrition and exercise as well as educationon these as the major types of interventions. Otherinterventions that cannot be assigned to one of thesecategories, such as acupuncture and moxibustiontherapy, music therapy, and survey, are classified into“Other.”The percentage of clinical trials targeting obesityhas been increasing year by year. This trend is clearfrom the residuals adjusted for degrees of freedom.While all residuals in clinical trials targeting obesityconducted years ago take negative values, all residualsin recent clinical trials take positive values. Table 2shows the yearly trends of interventions used inclinical trials targeting obese patients. Looking at theresiduals adjusted for degrees of freedom afterconducting a chi-squared test, we clearly found thatthe number of clinical trials using lifestyleintervention has been increasingKeywords: Obesity; Metabolic syndrome; Clinicaltrials

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Pharmaceutics & Organic Process Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Pharmaceutics & Organic Process Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Sato H”